drugset / Trial / NCT02510118
Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients
Phase 2/3
Unknown
360 enrolled
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Jiangsu Province Hospital of Traditional Chinese Medicine · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of this study is to evaluate the synergistic anti-tumor effect of ChangTai Keli based on chemotherapy for colon cancer patients by a randomized, parallel-group, double-blind, multicenter clinical study.
Timeline
- Start
- 2015-06
- Primary completion
- 2016-06
- Completion
- 2018-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ChangTai Keli | Traditional medicine (herbal / TCM) | — | — |
| Background | Capecitabine | Small molecule | 1000 mg/m2 | — |
| Background | Leucovorin | Small molecule | 400 mg/m2 | — |
| Background | Oxaliplatin | Small molecule | 85 mg/m2 | Intravenous |
| Background | Oxaliplatin | Small molecule | 130 mg/m2 | Intravenous |
| Background | fluorouracil | Small molecule | 2400 mg/m2 | Intravenous |